Improvements in muscle recovery and delayed onset muscle soreness (DOMS) reduction after eccentric exercise with the BounceBack™ product: a randomised, double-blind, two-way crossover, placebo-controlled, pilot study

Mannatech, Inc (USA)0 sites10 target enrollmentOctober 9, 2008

Overview

No summary available.

Registry

who.int

Start Date

October 9, 2008

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Sex

All

Sponsor

Mannatech, Inc (USA)

•1\. Both males and females, age \>\=18 and \<\=45 at screening
•2\. Body mass index (BMI) \>18 kg/m^2 and \<\=30 kg/m^2 at screening
•3\. Recreationally active but non\-resistance trained for the preceding 3 months
•4\. Agree to dietary modifications for the day prior to each visit
•5\. Subject agrees to all study visits
•6\. Must agree to use appropriate birth control methods during the active study

•1\. Non\-compliance during the screening phase of the study
•2\. Weight loss of \>10 pounds in the last 6 months
•3\. Pregnant or lactating
•4\. Currently attempting to become pregnant
•5\. Use of medications or supplements promoting weight gain (steroids, high\-protein supplements)
•6\. Daily use of acid blocking medication. Must agree to withhold acid blocking medication while on study (Includes all prescription and over the counter acid blockers including PPIs, H2RAs, and calcium carbonate \[Tums]).
•7\. Cigarette smoking
•8\. Abnormal physical examination
•9\. Subjects unable to understand or follow the study protocol
•10\. Subjects participating or participated in another clinical trial during the 1 month prior to screening